These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6711201)

  • 21. Evolution of the typhoid immunity along one year after intradermal vaccination.
    Dimache G; Croitoru M; Ciordaş C; Velea V
    Arch Roum Pathol Exp Microbiol; 1986; 45(2):147-52. PubMed ID: 3800632
    [No Abstract]   [Full Text] [Related]  

  • 22. [The characteristics of the reactogenicity and immunological activity of a new cholera bivalent chemical vaccine based on the results of controlled trials].
    Sumarokov AA; Ivanov NR; Dzhaparidze MN; Rystsova EA; Reznikov IuB; Matusevich LIa; Nikitina GP; Eliseev IuIu; Adamova GV; Plotnikova MN
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Jul; (7):55-8. PubMed ID: 1719716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and efficacy of combined meningococcal and typhoid vaccine.
    Khoo SH; St Clair Roberts J; Mandal BK
    BMJ; 1995 Apr; 310(6984):908-9. PubMed ID: 7719181
    [No Abstract]   [Full Text] [Related]  

  • 24. Intradermal typhoid vaccination in men by jet-injector. Immunological estimation by laboratory tests.
    Dimache G; Dimache V; Ciudin L; Palade R; Croitoru M
    Arch Roum Pathol Exp Microbiol; 1977; 36(3-4):227-32. PubMed ID: 617039
    [No Abstract]   [Full Text] [Related]  

  • 25. A single dose, combined vaccine against typhoid fever and hepatitis A: consistency, immunogenicity and reactogenicity.
    Beran J; Beutels M; Levie K; Van Damme P; Dieussaert I; Gillet M; Van Hoecke C; Tornieporth N
    J Travel Med; 2000; 7(5):246-52. PubMed ID: 11231208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Use of a jet injector for administration of sorbed typhoid vaccine with polytoxoid].
    Kreĭnin LS; Volynskiĭ MIa; Vartanian IuP; Ozeretskovskiĭ NA; Rezepov FF
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Sep; (9):94-7. PubMed ID: 189534
    [No Abstract]   [Full Text] [Related]  

  • 27. [Reactogenicity and immunological effectiveness of an oral cholera chemical vaccine in a limited controlled experiment with human revaccination].
    Sumarokov AA; Ivanov NR; Lelikov VL; Dzhaparidze MN; Karaeva LT
    Zh Mikrobiol Epidemiol Immunobiol; 1978; (12):87-92. PubMed ID: 371293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Live oral typhoid vaccine Salmonella Typhi Ty21a - a surrogate vaccine against non-typhoid salmonella?
    Kantele A; Pakkanen SH; Siitonen A; Karttunen R; Kantele JM
    Vaccine; 2012 Nov; 30(50):7238-45. PubMed ID: 23084770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Jet method of immunizing with associated sorbed vaccines].
    Agafonov VI; Babkin EI; Bulatova TI; Gamleshko GP; Gapochko KG
    Voen Med Zh; 1974 Dec; (12):44-8. PubMed ID: 4446401
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of aceclidine and fenazepam on the indices of humoral immunity and nonspecific resistance of the body after immunization with a chemical typhoid vaccine].
    Zabrodskiĭ PF; Kazakov VN
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Feb; (2):32-6. PubMed ID: 2896416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concomitant vaccination against hepatitis A and typhoid fever.
    Van Hoecke C; Lebacq E; Beran J; Prymula R; Collard F
    J Travel Med; 1998 Sep; 5(3):116-20. PubMed ID: 9772328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials.
    Bhutta ZA; Capeding MR; Bavdekar A; Marchetti E; Ariff S; Soofi SB; Anemona A; Habib MA; Alberto E; Juvekar S; Khan RM; Marhaba R; Ali N; Malubay N; Kawade A; Saul A; Martin LB; Podda A
    Lancet Infect Dis; 2014 Feb; 14(2):119-29. PubMed ID: 24290843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of vi-tetanus toxoid conjugated typhoid vaccine (PedaTyph™) in Indian children: School based cluster randomized study.
    Mitra M; Shah N; Ghosh A; Chatterjee S; Kaur I; Bhattacharya N; Basu S
    Hum Vaccin Immunother; 2016 Apr; 12(4):939-45. PubMed ID: 26901576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The relationship of antibody formation in immunization against typhoid fever to the acetylation phenotype].
    Guliamov NG; Musabaev EI; Bakhtiiarov ER; Kalendarev EL; Safarova DD
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Apr; (4):76-9. PubMed ID: 2385994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The comparative effectiveness, under epidemic conditions, of the intradermal versus subcutaneous antityphoid vaccination estimated by epidemiological surveillance and laboratory tests.
    Dimache G
    Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Aug; 262(2):220-9. PubMed ID: 3788347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and immunogenicity of Salmonella typhi Ty21a liquid formulation vaccine in 4- to 6-year-old Thai children.
    Olanratmanee T; Levine M; Losonsky G; Thisyakorn V; Cryz SJ
    J Infect Dis; 1992 Aug; 166(2):451-2. PubMed ID: 1634818
    [No Abstract]   [Full Text] [Related]  

  • 37. A single shot at Salmonella typhi: a new typhoid vaccine with pediatric advantages.
    Hall CB
    Pediatrics; 1995 Aug; 96(2 Pt 1):348-50. PubMed ID: 7630698
    [No Abstract]   [Full Text] [Related]  

  • 38. [A chemical typhoid vaccine containing a surface-antigen complex including the K-antigen].
    Stepanova LK; Belaia IuA; Sergeeva NS; Ageeva VA; Petrukhin VG
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (1):51-6. PubMed ID: 7520650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Study of the immunogenicity and immunological effectiveness of choleragen anatoxin. (data from a controlled epidemiological experiment). 3. The determination of the optimum inoculation doses of choleragen anatoxin for the immunization of children of different ages and of adolescents].
    Sumarokov AA; Lelikov VL; Ivanov NR; Poliakov KA; Dzhaparidze MH
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Dec; (12):32-8. PubMed ID: 4616552
    [No Abstract]   [Full Text] [Related]  

  • 40. [The immunogenic capacity of soluble "vaccinia" antigen (fractionated smallpox vaccine) administered simultaneously with inactivated typhoid vaccine and with purified and concentrated tetanus anatoxin].
    Mihăilescu R; Dimache G; Velea V; Stoean C; Croitoru M; Durbacă S; Chirescu N
    Arch Roum Pathol Exp Microbiol; 1989; 48(2):151-6. PubMed ID: 2699409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.